The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gullans Steven R. Ph.d. since 2013.
The trader's CIK number is 1571997.
At the time of the last reporting, Gullans Steven R. Ph.d. was the Director of Gemphire Therapeutics Inc.. (stock ticker symbol GEMP).
Also see all insider trading activities at Gemphire Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | GEMP | 52,798 | $499,997 | 0 | $0 | 0 | $0 |
| 2016 | GEMP | 500,000 | $5,000,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | TTPH | 25,000 | $230,975 | 0 | $0 | 0 | $0 |
| 2013 | TTPH | 496,121 | $3,472,847 | 0 | $0 | 0 | $0 |
1. Gemphire Therapeutics Inc. (GEMP)
2. Tetraphase Pharmaceuticals Inc (TTPH)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-10 | GEMP | Buy | 52,798 | 9.47 | 499,997 |
| 2016-08-10 | GEMP | Buy | 500,000 | 10.00 | 5,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-05-19 | TTPH | Buy | 25,000 | 9.24 | 230,975 |
| 2013-03-25 | TTPH | Buy | 496,121 | 7.00 | 3,472,847 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gullans Steven R. Ph.d. (Director of Gemphire Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.